Cannabigerol Reduces Acute and Chronic Hypernociception in Animals Exposed to Prenatal Hypoxia-Ischemia

• Autori principali: Bismarck Rezende (Autore), Kethely Lima Marques (Autore), Filipe Eloi Alves de Carvalho (Autore), Vitória Macario de Simas Gonçalves (Autore), Barbara Conceição Costa Azeredo de Oliveira (Autore), Gabriela Guedes Nascimento (Autore), Yure Bazilio dos Santos (Autore), Fernanda Antunes (Autore), Penha Cristina Barradas (Autore), Fabrícia Lima Fontes-Dantas (Autore), Guilherme Carneiro Montes (Autore)
• Natura: Libro
• Pubblicazione: MDPI AG, 2024-09-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Cannabigerol (CBG), a phytocannabinoid, has shown promise in pain management. Previous studies by our research group identified an increase in pain sensitivity as a consequence of prenatal hypoxia-ischemia (HI) in an animal model. This study aimed to investigate the efficacy of CBG in acute and chro...